CL2021000415A1 - Vesículas derivadas de lactobacillus paracasei y uso de las mismas - Google Patents
Vesículas derivadas de lactobacillus paracasei y uso de las mismasInfo
- Publication number
- CL2021000415A1 CL2021000415A1 CL2021000415A CL2021000415A CL2021000415A1 CL 2021000415 A1 CL2021000415 A1 CL 2021000415A1 CL 2021000415 A CL2021000415 A CL 2021000415A CL 2021000415 A CL2021000415 A CL 2021000415A CL 2021000415 A1 CL2021000415 A1 CL 2021000415A1
- Authority
- CL
- Chile
- Prior art keywords
- lactobacillus paracasei
- vesicles derived
- extracellular vesicle
- vesicle derived
- derived
- Prior art date
Links
- 241000186605 Lactobacillus paracasei Species 0.000 title abstract 3
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención se refiere a una vesícula extracelular derivada de Lactobacillus paracasei y a un uso de la misma, y más particularmente, a una composición para aliviar, prevenir o tratar una enfermedad inflamatoria y un cáncer, que comprende como un ingrediente activo una vesícula extracelular derivada de Lactobacillus paracasei, que puede inhibir de manera efectiva varias enfermedades inflamatorias, y similares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20180174027 | 2018-12-31 | ||
KR1020190048671A KR102098067B1 (ko) | 2018-12-31 | 2019-04-25 | 락토바실러스 파라카제이 유래 소포 및 이의 용도 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2021000415A1 true CL2021000415A1 (es) | 2021-09-20 |
Family
ID=70291099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2021000415A CL2021000415A1 (es) | 2018-12-31 | 2021-02-17 | Vesículas derivadas de lactobacillus paracasei y uso de las mismas |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3912631A4 (es) |
JP (2) | JP2022514977A (es) |
KR (1) | KR102098067B1 (es) |
CN (1) | CN113260372A (es) |
AU (1) | AU2019419281B2 (es) |
BR (1) | BR112021003728A2 (es) |
CA (1) | CA3112889A1 (es) |
CL (1) | CL2021000415A1 (es) |
MX (1) | MX2021002412A (es) |
MY (1) | MY195500A (es) |
PH (1) | PH12021550985A1 (es) |
SG (1) | SG11202104315XA (es) |
WO (1) | WO2020141685A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3099668C (en) * | 2018-05-09 | 2023-10-03 | Kobiolabs, Inc | Lactobacillus paracasei strain and use thereof |
KR102257130B1 (ko) * | 2020-06-16 | 2021-05-28 | 주식회사 엠디헬스케어 | 락토바실러스 파라카세이 유래 소포를 포함하는 신경질환 또는 정신질환 예방 또는 치료용 조성물 |
EP3957316B1 (en) | 2020-06-16 | 2024-02-07 | MD Healthcare Inc. | Composition for preventing or treating neurological or mental disorders comprising vesicles derived from lactobacillus paracasei |
US20230338439A1 (en) * | 2020-07-14 | 2023-10-26 | Liscure Biosciences Co., Ltd | Composition for treating brain disease comprising pediococcus inopinatus or extracellular vesicles isolated therefrom as active ingredient |
KR102512516B1 (ko) | 2021-04-02 | 2023-03-22 | 한국과학기술연구원 | 옵투시폴린 (obtusifolin), 이의 유도체, 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 퇴행성관절염의 예방 또는 치료용 약제학적 조성물 |
CN115305211A (zh) * | 2021-05-07 | 2022-11-08 | 葡萄王生技股份有限公司 | 益生菌胞外泌体及其用途 |
EP4349354A1 (en) * | 2021-06-03 | 2024-04-10 | MD Healthcare Inc. | Extracellular vesicles derived from lactobacillus bacteria, and use thereof |
KR20220169403A (ko) * | 2021-06-18 | 2022-12-27 | 한국생명공학연구원 | 락티카제이바실러스 속 또는 락토바실러스 속 균주를 유효성분으로 포함하는 암 진단, 예방 또는 치료용 조성물 |
KR20230015688A (ko) * | 2021-07-23 | 2023-01-31 | (주) 에이투젠 | 신규한 락토바실러스 파라카제이 atg-e1 균주 또는 이를 포함하는 호흡기 질환의 예방 또는 치료용 조성물 |
CN114085792B (zh) * | 2021-11-17 | 2023-03-24 | 哈尔滨医科大学 | 一种用于防治结肠癌的副干酪乳杆菌及其应用 |
CN114540227B (zh) * | 2022-02-21 | 2023-06-23 | 南京医科大学 | 一种具有抑制肝癌肿瘤生长的副干酪乳杆菌l511及其用途 |
KR20230136548A (ko) | 2022-03-18 | 2023-09-26 | 주식회사 엠디헬스케어 | 수율이 향상된 유산균 유래 세포외소포의 제조방법 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120087902A1 (en) * | 2009-07-20 | 2012-04-12 | Bracco S.P.A. | Therapeutic Use Of Probiotics |
KR101109744B1 (ko) * | 2009-11-13 | 2012-03-13 | 충청북도 (관리부서:충청북도 농업기술원) | 균체외 다당을 생성하고 건강기능성 효과를 갖는 신규한 락토바실러스 파라카제이 |
KR101629525B1 (ko) * | 2010-01-11 | 2016-06-13 | 이화여자대학교 산학협력단 | 발효식품에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도 |
EP2589391B1 (en) * | 2010-07-01 | 2018-11-14 | Rosetta Exosome Co., Ltd. | Bacterial cell-derived microvesicles for use in a method of treating cancer |
KR101427363B1 (ko) * | 2011-11-23 | 2014-08-08 | 주식회사 쎌바이오텍 | 항암 약제학적 조성물 |
CN113046285A (zh) * | 2012-04-06 | 2021-06-29 | 康奈尔大学 | 用于稳健的体液及细胞免疫应答的亚单位疫苗递送平台 |
KR101620815B1 (ko) | 2014-05-21 | 2016-05-13 | 한국생명공학연구원 | 해양 진균에서 분리한 페니실리놀라이드 a를 유효성분으로 함유하는 염증성 질환 예방 및 치료용 조성물 |
KR101644595B1 (ko) * | 2014-07-11 | 2016-08-03 | 한국식품연구원 | 락토바실러스 파라카제이(Lactobacillus paracasei)를 유효성분으로 포함하는 Th1-매개 면역 질환 또는 Th2-매개 면역 질환의 예방, 개선 또는 치료용 조성물 |
KR20160110232A (ko) * | 2015-03-11 | 2016-09-21 | 주식회사 엠디헬스케어 | 유산균 유래 세포밖 소포체를 유효성분으로 포함하는 염증질환의 예방 또는 치료용 조성물 |
CN104894021B (zh) * | 2015-06-03 | 2018-02-09 | 宜兰食品工业股份有限公司 | 一种副干酪乳杆菌及其应用 |
KR102027029B1 (ko) * | 2017-05-25 | 2019-09-30 | (주)엠앤씨생명과학 | 유산균 함유 천연 리포좀, 그 제조방법 및 이를 포함하는 식품 또는 약학 조성물 |
KR101984022B1 (ko) | 2017-10-31 | 2019-09-03 | 한국생산기술연구원 | 콤팩트하고 단순화한 사류 펌프의 디퓨저 설계 방법, 이에 의하여 설계된 디퓨저 및 이를 구비한 사류 펌프 |
-
2019
- 2019-04-25 KR KR1020190048671A patent/KR102098067B1/ko active IP Right Grant
- 2019-08-13 JP JP2021537084A patent/JP2022514977A/ja active Pending
- 2019-08-13 CA CA3112889A patent/CA3112889A1/en active Pending
- 2019-08-13 MX MX2021002412A patent/MX2021002412A/es unknown
- 2019-08-13 SG SG11202104315XA patent/SG11202104315XA/en unknown
- 2019-08-13 AU AU2019419281A patent/AU2019419281B2/en active Active
- 2019-08-13 BR BR112021003728-4A patent/BR112021003728A2/pt unknown
- 2019-08-13 MY MYPI2021003752A patent/MY195500A/en unknown
- 2019-08-13 EP EP19907069.9A patent/EP3912631A4/en active Pending
- 2019-08-13 WO PCT/KR2019/010267 patent/WO2020141685A1/ko unknown
- 2019-08-13 CN CN201980087214.8A patent/CN113260372A/zh active Pending
-
2021
- 2021-02-17 CL CL2021000415A patent/CL2021000415A1/es unknown
- 2021-04-30 PH PH12021550985A patent/PH12021550985A1/en unknown
-
2023
- 2023-05-24 JP JP2023085584A patent/JP2023109943A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PH12021550985A1 (en) | 2021-11-08 |
JP2023109943A (ja) | 2023-08-08 |
WO2020141685A1 (ko) | 2020-07-09 |
KR102098067B1 (ko) | 2020-04-07 |
CA3112889A1 (en) | 2020-07-09 |
BR112021003728A2 (pt) | 2021-05-25 |
MY195500A (en) | 2023-01-26 |
EP3912631A1 (en) | 2021-11-24 |
CN113260372A (zh) | 2021-08-13 |
EP3912631A4 (en) | 2022-11-30 |
AU2019419281B2 (en) | 2023-11-30 |
MX2021002412A (es) | 2021-04-28 |
JP2022514977A (ja) | 2022-02-16 |
AU2019419281A1 (en) | 2021-03-04 |
SG11202104315XA (en) | 2021-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2021000415A1 (es) | Vesículas derivadas de lactobacillus paracasei y uso de las mismas | |
CO2019004137A2 (es) | 1,2,4–triazolonas 2,4,5–trisustituidas | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
CO2017004525A2 (es) | Dihidropirrolopiridinas inhibidoras de ror-gamma | |
DOP2016000109A (es) | Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas. | |
UY36665A (es) | Derivados de ciclohexano sustituidos con amidas | |
UY34605A (es) | Derivados de arilalquiloxipirimidina e insecticidas agrohortícolas que comprenden dichos derivados como principios activos, y método de uso de los mismos | |
UY34750A (es) | ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?. | |
UY34545A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios. | |
CO2018001628A2 (es) | Composiciones y formulaciones antimicrobianas | |
UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
NI201500115A (es) | Estra-1,3,5(10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3) | |
MY193312A (en) | Topical formulation for promoting wound healing | |
CL2017000845A1 (es) | Inhibidores de gingipaina de lisina | |
CO2017002813A2 (es) | Derivados estabilizados de adrenomedulina y uso de los mismos | |
CR20160529A (es) | Composiciones farmacéuticas para tratar enfermedades infecciosas | |
NI202000042A (es) | Polimorfos | |
MX362155B (es) | Combinaciones de alquilamidotiazoles y sustancias aromaticas. | |
UY34543A (es) | Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica. | |
BR112017018618A2 (pt) | odorizante de osmanthus | |
BR112018003945A2 (pt) | extrato de gardenia para tonalizar a pele | |
MX2019012375A (es) | Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1). | |
GT201300225A (es) | Tieno (2,3-d) derivados de pirimidina y su uso para el tratamiento de la arritmia | |
AR086689A1 (es) | Auxiliar de la formulacion para la desinfeccion de semillas | |
BR112019017314A2 (pt) | composições farmacêuticas para terapia de combinação |